3/27
10:08 am
vnrx
VolitionRx Limited (NYSE: VNRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $2.50 price target on the stock.
Low
Report
VolitionRx Limited (NYSE: VNRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $2.50 price target on the stock.
3/27
09:54 am
vnrx
Rating for VNRX
Low
Report
Rating for VNRX